期刊文献+

脊髓灰质炎减毒活疫苗的高效纯化及特性研究 被引量:1

Studies on the Purification of OPV and its Characterization
下载PDF
导出
摘要 应用Q SepharoseFastFlow对Vero细胞基质制备的I型口服脊髓灰质炎减毒活疫苗悬液进行纯化。病毒液经滤过澄清和超滤浓缩 ,获得 85%的病毒感染性滴度回收率 ,而经Q SepharoseF .F .纯化的病毒悬液 ,病毒感染性滴度回收率达 10 0 %。纯化后的病毒液用α 32 PdATP标记DNA探针膜杂交法测定 ,宿主Vero细胞基质DNA残余含量远低于 10 0 pg/剂量的标准 ;rct/ 4 0特征、病毒形态及病毒衣壳蛋白组份等生物学性状无显著变化。研究结果提示 ,Q SepharoseF .F .是Vero细胞制备口服脊髓灰质炎减毒疫苗的理想纯化材料。 Q Sepharose F.F. was adopted to purify the suspension of oral poliovaccine (OPV), which is prepared from Vero cells. After clarification and concentration by ultrafiltration, the recovery of virus infected titre may attain above 85%. Using column chromatography on Q Sepharose F.F. to purify the concentrated virus suspension, the purified viruses attain 100% recovery of virus infectivity. Dot membrane hybridization was used to detect DNA with the probe of Vero cell genome DNA which was labed with α 32 P dATP, the contents of residual substrate DNA was less than 100 pg/dose. The process of downstream had no significant influence on some biologiccal characters of purified viruses, such as virus morphology, tumorigenicity, rct/40 character and capsid protein. The results indicate that Q Sepharose F.F. is an ideal chromatography material for purifying OPV prepared from Vero cells.
出处 《中国病毒学》 CSCD 2000年第3期226-231,共6页 Virologica Sinica
关键词 脊髓灰质炎减毒活疫苗 凝胶柱层析 高效纯化 Oral polio vaccine (OPV) Q Sepharose F.F. Purification
  • 相关文献

参考文献14

  • 1[1] Hayflick L. History of the cell substrates used for human biologicals [J]. Develop Biol Standard, 1989,70:11-26
  • 2[2] Horaud F. Absence of viral sequences in the WHO Vero cell bank: A collaborative study [J]. Develop Biol Standard, 1992,76:43-46
  • 3[3] Nontagnon B. 1000 liter scale microcarrier culture of Vero cells for killed poliovirus vaccine-promising results [J]. Develop Biol Standard, 1983,55:37-42
  • 4[4] Florian H. Viral vaccines and residual cellular DNA [J]. Biologicals, 1995,23:225-228
  • 5[5] WHO. Requirements for Poliomyelitis vaccine (ORAL) [S]. WHO TRS, 1990,800:30-65
  • 6[6] Sepharose ion exchangers. Ion Exchange Chromatography: principles & methods [R]. Pharmacia, 1993,10-12
  • 7[7] James S R. A collaborative study on DNA quantitation in biological products [J]. Biologicals, 1995,23:199-205
  • 8[8] Floyd R, Sharp D G. Viral aggregation: Buffer effects in the aggregation of Poliovirus and reovirus at low and high pH [J]. Appl Environ Microbiol, 1979,38(3):395-401
  • 9[9] John C, Horaud F N. DNA, dragons and sanity [J]. Biologicals, 1995,23:233-238
  • 10[10] Chezzi C. Genetic stability of oral poliovaccine prepared on primary monkey cells or Vero cells-effects of passage in cell culture and the human gastrointestinal truct [J]. Vaccine, 1998,16:2031-2038

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部